|
|
||||||||
|
FIGURE 2. Images comparing pretherapy 111In-octreotide scintigraphy (A) and posttherapy 177Lu-DOTATATE scintigraphy at 24 h (B). Top row shows corresponding images of tumor sites in patient 1 with metastatic PTC. Bottom row shows corresponding images of patient 3 with HCTC.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |